FASLG and cancer: Cancer cells can drive immune suppression by multiple mechanisms, including the secretion of immune-suppressive cytokines and chemokines, such as TGFβ and IL-10 [56], or FasL expressing microvesicles (TMV) which induce lymphocyte apoptosis [57].